A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma
Clinical trial NCT04039607 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04039607
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-30
- Primary completion
- 2026-07-09
- Enrollment
- 732
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.